Abstract
Human primary breast cancers and breast cancer cell lines are classified by microarray-defined molecular subtypes, which reflect differentiation characteristics. Estrogen receptor (ER) expression is indicative of the luminal molecular subtype. We have previously established IPH-926, the first well-characterized cell line from infiltrating lobular breast cancer. IPH-926 displays an ER/PR/ErbB2 triple-negative immunophenotype, which is due to a loss of ER expression in its in vivo clonal ancestry. Loss of ER might indicate a fundamental change of cellular differentiation and it is unclear whether a luminal subtype is preserved beyond ER conversion. Using Affymetrix microarray analysis, seven different classifier gene lists (PAM305, DISC256, TN1288, PAM50, UNC1300, LAB704, INT500) and a background population of 50 common mammary carcinoma cell lines, we have now determined the molecular subtype of IPH-926. Strikingly, the IPH-926 expression profile is highly consistent with a luminal subtype. It is nearest to luminal/ER-positive breast cancer cell lines and far apart from basal breast cancer cell lines. Quantitative real-time RT-PCR confirmed enhanced expression of luminal marker genes (AGR2, CLU, CA12, EMP2, CLDN3) and low or abs...Continue Reading
References
Aug 30, 2000·Nature·C M PerouD Botstein
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
May 18, 2005·Oncogene·Pierre FarmerRichard Iggo
Apr 29, 2006·BMC Genomics·Zhiyuan HuCharles M Perou
Dec 13, 2006·Cancer Cell·Richard M NeveJoe W Gray
Nov 14, 2007·International Journal of Cancer. Journal International Du Cancer·Brenda J BoersmaStefan Ambs
Apr 10, 2008·International Journal of Cancer. Journal International Du Cancer·François BertucciDaniel Birnbaum
Feb 5, 2009·The Journal of Pathology·Matthias ChristgenUlrich Lehmann
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel S ParkerPhilip S Bernard
Jul 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Klaus P HoeflichMark R Lackner
Jul 8, 2009·PloS One·Jessica KaoJonathan R Pollack
Jul 14, 2009·Breast Cancer Research and Treatment·Antoinette HollestelleMieke Schutte
Oct 31, 2009·The Journal of Pathology·Britta WeigeltJorge S Reis-Filho
May 22, 2010·Breast Cancer Research and Treatment·Renaud SabatierFrançois Bertucci
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Jun 3, 2011·Breast Care·Michael GnantChristoph Thomssen
Jun 28, 2011·The EMBO Journal·Jessica L L RobinsonJason S Carroll
Jul 26, 2011·Oncogene·M GuedjC Theillet
Sep 1, 2011·Nature Reviews. Clinical Oncology·Britta WeigeltJorge S Reis-Filho
Sep 3, 2011·Breast Cancer Research : BCR·Deborah L Holliday, Valerie Speirs
Nov 29, 2011·Cancer Letters·Till KrechMatthias Christgen
Mar 15, 2012·Cancer·Laurien D C HoefnagelPaul J van Diest
Sep 5, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Matthias ChristgenUlrich Lehmann
Sep 4, 2013·Breast Care·Nadia HarbeckMichael Gnant
Citations
Mar 12, 2015·Breast Cancer Research : BCR·Matthias Christgen, Patrick W B Derksen
Sep 1, 2015·PloS One·Ton van AgthovenMatthias Christgen
Aug 28, 2018·Statistical Methods in Medical Research·Pieter SegaertPeter J Rousseeuw
Oct 17, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Mieke RaapMatthias Christgen
Oct 28, 2019·Cancers·Mohammad Khusni B Ahmat AminHisakazu Ogita
Mar 29, 2020·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Yier QiuYingjie Wu
Aug 17, 2020·BMC Bioinformatics·Hongwei SunTong Wang
Jul 19, 2017·Journal of Global Oncology·Evelyn JiaggeBaffour Awuah
Aug 8, 2021·Cancers·Matthias ChristgenAnne Vincent-Salomon